Cargando…
SAT149 In Vitro Characterization Of A Novel Long-acting Glucagon Analog (HM15136) And Its Potential Effect In Animal Models Of Chronic Hypoglycemic Diseases
Disclosure: J. Kim: Employee; Self; Hanmi Pharm. Co., Ltd. Y. Kim: Employee; Self; Hanmi Pharm. Co., Ltd. B. Ye: Employee; Self; Hanmi Pharm. Co., Ltd. W. Kim: Employee; Self; Hanmi Pharm. Co., Ltd. J. Kim: Employee; Self; Hanmi Pharm. Co., Ltd. S. Bae: Employee; Self; Hanmi Pharm. Co., Ltd. D. Kim:...
Autores principales: | Kim, Jung Kuk, Kim, Yohan, Ye, Byeongjin, Kim, Wonki, Kim, Jeong A, Bae, Sungmin, Kim, Daejin, Lee, Sang Hyun, Choi, In Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555280/ http://dx.doi.org/10.1210/jendso/bvad114.1014 |
Ejemplares similares
-
PSUN305 A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities
por: Shin, Wonjung, et al.
Publicado: (2022) -
A novel glucagon analog with an extended half-life, HM15136, normalizes glucose levels in rodent models of congenital hyperinsulinism
por: Heo, Yong Ho, et al.
Publicado: (2022) -
SAT147 A Pharmacist Driven Active Surveillance Program To Reduce Hypoglycemic Recurrences In The Inpatient Setting
por: Kim, Steve, et al.
Publicado: (2023) -
SAT132 Isolated Elevated Hemoglobin A1c At Early Diagnosis Of Gestational Diabetes Does Not Predict Need For Hypoglycemic Agents
por: Markovic, Emily S, et al.
Publicado: (2023) -
SAT-149 The Metabolic Impairments Caused by Fructose and Prednisolone Intake Are Reversible After the Interruption of Exposure
por: Rafacho, Alex, et al.
Publicado: (2019)